Yes, that certainly is the question that comes to mind when reading the press release and wondering why there was no mention about the control group. The little knowledge I have about ALS trials is that they do have placebo response issues, no different than most other disease studies. I have tried getting more information from both the company and the trial team, but to no avail. I was told that there will be a more detailed report coming out soon. Also, they are definitely moving forward with a larger, longer-term trial. As they are a small company, yet self-sponsoring the trial at their own expense, I'm hoping that they are satisfied that they have seen more than just a placebo response.

With regard to our main interest, PD, I was also told that they are planning a larger trial to begin later this year.